CAPPED BONUSZERTIFIKAT - FRESENIUS MEDICAL CARE Share Price

Certificat

DE000DJ33DM0

Delayed Deutsche Boerse AG 12:04:29 29/05/2024 am IST
54.05 EUR +0.58% Intraday chart for CAPPED BONUSZERTIFIKAT - FRESENIUS MEDICAL CARE
Current month+5.15%
1 month+9.03%
Date Price Change
29/24/29 54.05 +0.58%
27/24/27 53.74 +0.45%
24/24/24 53.5 +1.38%
23/24/23 52.77 -1.24%
22/24/22 53.43 -1.17%

Delayed Quote Deutsche Boerse AG

Last update May 29, 2024 at 12:04 am IST

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
Issuer DZ BANK
WKN DJ33DM
ISINDE000DJ33DM0
Date issued 13/07/2023
Strike 60
Maturity 20/12/2024 (206 Days)
Parity 1 : 1
Emission price 52.62
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 55.01
Lowest since issue 35.35
Spread 0.05
Spread %0.09%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
38.77 EUR
Average target price
39.84 EUR
Spread / Average Target
+2.77%
Consensus